EMACOLEX, May 2011 Recent activities of the HMA/EMA Transparency Group Tina Engraff Legal Adviser, Danish Medicines Agency.

Slides:

Advertisements

Similar presentations

ENTITIES FOR A UN SYSTEM EVALUATION FRAMEWORK 17th MEETING OF SENIOR FELLOWSHIP OFFICERS OF THE UNITED NATIONS SYSTEM AND HOST COUNTRY AGENCIES BY DAVIDE.

Advertisements

1 Sub-group on Process Efficiency 1 st meeting, 17 Nov 2008 Frankfurt am Main T2S Project Team European Central Bank.

Health and Safety Executive Health and Safety Executive Hot Topics Kate Haire Head of Small Medium and Low Risk Business Team.

Table of contents 1 Manual of Operational Procedures (MOP) 2

IEP Amendment Podcast Script Shirley Young, Consultant, OSE-EIS January 13,

CMD(h) Report Progress report Truus Janse-de Hoog HMA meeting Budapest April 2011.

Slide 1 November 2008 Name Sarah Morgan © Crown copyright 2005 Pharmacovigilance Working Party - Role and future perspective Sarah Morgan Medicines and.

Equality and non-discrimination in an enlarged EU Green Paper.

Culture Programme - Selection procedure Katharina Riediger Infoday Praha 10/06/2010.

An agency of the European Union Presented by: David Mackay Head of Unit, Veterinary Medicines & Product Data Management Unit Incident Management Plan Veterinary.

Report - HMA/EMEA Office of Training Steering Group Dr. Gro Ramsten Wesenberg Co-chair.

1 10 th Annual European Scientific and Regulatory Affairs Conference New Pharmaceutical legislation: One year experience… 21 November 2006 Bernard Lemoine.

An agency of the European Union Presented by: Emer Cooke and Truus Janse-de Hoog Update on Transparency Progress report from HMA/EMA TF on Transparency.

Code of Practice 13/ DC Regulatory Guidance. Agenda Background Code of Practice 13 v. DC Regulatory Guidance DC Focus areas Action: Timeline 2.

Paediatric Worksharing CMDh participation Work-sharing in Art 45 and 46 procedures Experiences in Art 29 procedures Presidency meeting 29 September 2011.

Recommendation 2001/331/EC: Review and relation to sectoral inspection requirements Miroslav Angelov European Commission DG Environment, Unit A 1 Enforcement,

Advisory Committee for Diversity in the Digital Age.

3rd BERCEN Exchange Programme, Prague WASTE CONDITIONS IN ENVIRONMENTAL PERMITS Mrs. Marianne Lindström, Finnish Environmental Institute,

Scanner Data: Main changes and Eurostat's involvement Dirk-Jan Hoogerdijk Eurostat Unit C4 Price Statistics; Purchasing Power Parities; Housing Statistics.

Fitness Check of environmental monitoring and reporting MIG-P meeting 4 Dec 2015 Joachim D'Eugenio Steve White DG Environment European Commission.

Effective Justice? - Synthesis report in EC study on implementation of Art. 9.3 and 9.4 of the AC in 17 of the Union’s Member States; 2012 Presentation.

Status and role of International Department (Slovak experience) MGSC Meeting Luxembourg 23 – 24 March 2012 SOSR.

1 IFAD consideration of a Code of Conduct for Executive Board Representatives Historical Background Presentation to an Informal Seminar of the Executive.

An agency of the European Union Presented by: Noël Wathion Head of Unit, Patient Health Protection HMA – Human Agenda item 3: Implementation of the New.

Florence Forum, November 2008 Regulation (EC) 1228/ ERGEG Compliance Monitoring.

Water.europa.eu CIS Ad hoc activity on WFD Economic Issues -Progress Update Strategic Coordination Group Meeting, 23 February 2010 DG Environment, European.

European Patients’ Academy on Therapeutic Innovation Aspects of pharmacovigilance: Periodic Safety Update Reports (PSURs)

Health and Food Safety EU strategy for Pharmaceuticals in the Environment Patrizia Tosetti DG SANTE European Commission China/EU Pharmaceutical Industry.

Overview of the EU regulatory system and governance

“EMA policy on publication of Clinical Data” 27/11/2014SFdS - Journée Annuelle du groupe Biopharmacie & Santé.

Workshop on “EU Enlargement: Regulatory Convergence in Non-acceding Countries” Athens 7 – 8 November 2003 Regulatory Convergence and Technical Standards.

An agency of the European Union Guidance on the anonymisation of clinical reports for the purpose of publication in accordance with policy 0070 Industry.

Have your say on Pharmacy Services in Warrington

process and procedures for assessments

Strategic Initiative for Resource Efficient Biomass Policies

Eastern European Partner countries

Electronic communications services: Ensuring equivalence in access and choice for disabled end-users - Article 23a ERG/BEREC Project Public Hearing,

REWG activities in LILIIA MALON REWG Chair Prague

DG Environment, Unit D.2 Marine Environment and Water Industry

ESF transnational calls – Member State plans

VEG N° 070 REV1 - Meaning of "financial, economic and organisational links" among VAT group members Presentation to the VAT Committee by the VAT Expert.

List of priority spatial data sets

Readiness for e-submissions Veterinary medicines agencies

National Centre for Guidance in Education

GBV survey: progress EUROSTAT 20 March 2018.

Updating of the Reporting Guidance for the Floods Directive: Context

[draft] Conclusions, actions & next steps

MIWP Action ”Priority List of E-Reporting Datasets”

Compliance Item 4.2 Compliance Doc. ASA/TE/743-rev1

Proposed CIS Workshop on WFD Economic Issues

CIS work programme Ad-hoc activity on Economics

LAMAS Working Group 7-8 December 2015

The role of the ECCP (1) The involvement of all relevant stakeholders – public authorities, economic and social partners and civil society bodies – at.

Gender Based Violence – progress report Item 7 of the draft agenda

HPRA preparedness for Brexit

Information on projects

Natura 2000: points of information

Steering Committee, Eurostat, Luxembourg, 4 February 2011

[draft] Conclusions, actions & next steps

Session 1: The report on CIS-members´ views on the experience in the implementation of the economic aspects of the WFD.

Water scarcity & droughts

Item 4.2 – Towards the 2016 AES Philippe Lombardo Eurostat-F5

Handling the “stop of the clock” in product authorisation

Working Party on Fisheries Statistics 14 October 2013

Meeting of PAP/RAC Focal Points, Split, Croatia, 8-9 May 2019

IT security assurance – 2018 and beyond Item 2 of the agenda DIME/ITDG Steering Group June 2018 Pascal JACQUES ESTAT B2/LISO.

Scene setter European Commission DG Environment

Concept paper on the assessment of WFD River Basin Management Plans

Item 7. Paving the way for WFD in Cross Compliance

Implementing the ESS Vision 2020

Presentation transcript:

EMACOLEX, May 2011 Recent activities of the HMA/EMA Transparency Group Tina Engraff Legal Adviser, Danish Medicines Agency

EMACOLEX, May 2011 Background & purpose Membership Outcomes Current activities Future activities

EMACOLEX, May 2011 Background and purpose New transparency provision in the Review 2001 Need for harmonised approach between MS Questionnaires and meetings at EMA with all MS represented Smaller group emerged to take concrete actions forward Ad hoc tasks Produce guidance to facilitate a harmonised approach across EU, if possible

EMACOLEX, May 2011 Membership EMA, NL, ES, PT, DE, SE and DK –CMD(v) also involved, when relevant EMA and NL co-chairs –Emer Cooke and Truus Janse-de Hoog Pharmacists, biologist, international affairs, communication and lawyers

EMACOLEX, May 2011 Outcomes (1) Recommendations on transparency related to agendas/minutes on product related issues – nsparency.pdfhttp:// nsparency.pdf Recommendations on the handling of requests for access to PSURs – ions_on_Transparency pdfhttp:// ions_on_Transparency pdf

EMACOLEX, May 2011 Outcomes (2) Recommendations on release of information with regard to new applications for medicinal products – ns_NAReleaseinformation.pdfhttp:// ns_NAReleaseinformation.pdf Consultation procedure between NCAs in the EU when 3rd parties request access to assessment reports that have been written in the context of an European procedure involving more than one MS –Not to be published

EMACOLEX, May 2011 Current activities HMA/EMA guidance document on the identification of CCI and protection of personal data within the structure of the MA dossier – Release of information after the granting of a MA –CMD(h) + national lawyers had meeting 17 March –At HMA meeting in April 2011 agreed that a public consultation (3 months) could take place –Final version anticipated at HMA meeting in November 2011 –Final version to be published

EMACOLEX, May 2011 Future activities Further work on guidance on access to dossier Input to implementation of transparency issues in the new PhV legislation –Members of the HMA/EMA Transparency Group participates in project teams Possible input to idea of having dossier divided into confidential part and non-confidential part

EMACOLEX, May 2011 Thank you